These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 37643983)

  • 1. Construction of a prediction model for prognosis of bladder cancer based on the expression of ion channel-related genes.
    Zhang D; Yin G; Zheng S; Chen Q; Li Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):499-509. PubMed ID: 37643983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of bladder cancer based on immune cell infiltration and construction of a risk prediction model for prognosis.
    Yin G; Zheng S; Zhang W; Dong X; Qi L; Li Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):47-57. PubMed ID: 38229504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk modeling based on HER-2 related genes for bladder cancer survival prognosis assessment].
    Liu HR; Peng X; Li SL; Gou X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):793-801. PubMed ID: 37807731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer.
    Cao P; Chen M; Zhang T; Zheng Q; Liu M
    Eur J Med Res; 2023 Nov; 28(1):515. PubMed ID: 37968767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel gene-based model for prognosis prediction of head and neck squamous cell carcinoma.
    Li Y; Li P; Liu Y; Geng W
    Heliyon; 2024 Apr; 10(8):e29449. PubMed ID: 38660262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer.
    Lai F; He L; Lia T; Yang Z; Huang C
    Medicine (Baltimore); 2024 Jul; 103(29):e38858. PubMed ID: 39029072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of prognostic model of bladder cancer based on apoptosis-related genes, in which P4HB promotes BLCA progression.
    Zou Z; Li Z; Sun W; Gao W; Liu B; Liu J; Guo Y
    BMC Urol; 2023 Oct; 23(1):167. PubMed ID: 37845668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer.
    Yan X; Chen M; Xiao C; Fu J; Sun X; Hu Z; Zhou H
    Ann Med; 2021 Dec; 53(1):1048-1058. PubMed ID: 34187252
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression.
    Wang W; Ji W; Lyu Z; Sun W; Shao Y; Liu J; Yang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):98-107. PubMed ID: 38105682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Validation of a Prognostic Model of Metabolism-Related Genes Driven by Somatic Mutation in Bladder Cancer.
    Wei L; Ji L; Han S; Xu M; Yang X
    Front Biosci (Landmark Ed); 2023 Oct; 28(10):242. PubMed ID: 37919060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
    Zhang P; Xie X; Li C; Zhang C; Liang P
    Cancer Med; 2023 Oct; 12(19):19758-19776. PubMed ID: 37706625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and verification of anoikis-related gene markers to predict the prognosis of patients with bladder cancer and assist in the diagnosis and treatment of bladder cancer.
    Li H; Bao X; Xiao Y; Yin H; Han X; Kang S
    Transl Cancer Res; 2024 Feb; 13(2):579-593. PubMed ID: 38482431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer.
    Xu H; Sun D; Zhou D; Sun S
    Cancer Invest; 2024 Feb; 42(2):186-198. PubMed ID: 38390837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of prognostic risk markers for cervical cancer combined with anoikis-related genes and their clinical significance.
    Zhang J; Tian Y
    Reprod Fertil Dev; 2023 Nov; 35(16):677-691. PubMed ID: 37899003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of PANoptosis-related genes identifies XIAP as a functional oncogene in breast cancer.
    Qi Q; Zhu M; Li P; Mi Q; Xie Y; Li J; Wang C
    Gene; 2024 Jun; 912():148355. PubMed ID: 38467314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Modified NAR Scoring Model Incorporating Immune Infiltration Characteristics to Better Predict Long-Term Survival Following Neoadjuvant Radiotherapy in Rectal Cancer.
    Zhang X; Zeng Y; Li H; Zhuang Q; Tang L; Wu J; Li J
    Life (Basel); 2023 Oct; 13(11):. PubMed ID: 38004246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of coexpression genes of immune cells in breast cancer tissues.
    Zhang YY; Gan YM
    Medicine (Baltimore); 2024 Jan; 103(1):e36211. PubMed ID: 38181289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of TMEM40 in bladder cancer and its correlation with clinicopathological parameters.
    Zhang QY; Fu MT; Zhang ZF; Feng YZ; Wei M; Zhou JY; Shi R
    Int J Clin Exp Pathol; 2017; 10(7):8050-8057. PubMed ID: 31966657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of SRRM3 in bladder cancer predicts poor prognosis and is associated with immune infiltration.
    Chi J; Jiang X; Liu Q; Cui Y
    Asian J Surg; 2024 May; ():. PubMed ID: 38729873
    [No Abstract]   [Full Text] [Related]  

  • 20. PPP1R14A as a potential biomarker for predicting the progression and prognosis of bladder cancer.
    Lou K; Chi J; Zheng X; Cui Y
    Asian J Surg; 2024 May; ():. PubMed ID: 38762417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.